v3.25.2
Lease Obligations - Additional Information (Details)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended 37 Months Ended
Apr. 30, 2024
Sublease
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Apr. 30, 2027
USD ($)
Lessee Lease Description [Line Items]                
Other income related to subleases   $ (32) $ (172) $ 4 $ (49) $ 71 $ (137)  
Number Of Existing Leases           two    
Operating lease costs           $ 500 800  
IKENA ONCOLOGY INC                
Lessee Lease Description [Line Items]                
Other income related to subleases   4,708 235 5,493 228 2,518 (22)  
Letter of credit to secure lease   $ 872 $ 1,278 $ 872 $ 1,278 872 1,278  
Operating lease costs           2,758 2,316  
Sublease | IKENA ONCOLOGY INC                
Lessee Lease Description [Line Items]                
Other income related to subleases           1,000    
Pionyr Immunotherapeutics, Inc | IKENA ONCOLOGY INC                
Lessee Lease Description [Line Items]                
Number of sublease agreement | Sublease 3              
Letter of Credit | IKENA ONCOLOGY INC                
Lessee Lease Description [Line Items]                
Letter of credit to secure lease           $ 900 $ 1,300  
Forecast | Pionyr Immunotherapeutics, Inc | IKENA ONCOLOGY INC                
Lessee Lease Description [Line Items]                
Sublease agreements amount               $ 2,500